These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8302443)

  • 1. [Effect of calciparine in the mid-term treatment of peripheral arteriopathy of the lower extremities].
    Stanzani M; Colombo L; Altomare S; Pagnozzi G; Barbieri C; Bruschi R; Pietrasanta E
    Minerva Cardioangiol; 1993 Oct; 41(10):465-8. PubMed ID: 8302443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physical training and low-dose heparin-calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with intermittent claudication].
    Cina G; Vernich M; Campisi C; Cascone C; Ofria F; Leopardi N; Maniscalco G; Moricca N; Ceccarelli V; Paolicelli D; Carbone D
    Minerva Cardioangiol; 1996 Apr; 44(4):179-85. PubMed ID: 8767599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E; Leanza D; Giordano S; Nazzari M; Corsi C
    Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation at midterm of the clinico-instrumental efficacy and tolerance of picotamide in patients with obliterative arteriopathy of the lower limbs].
    Guarini P; Canonico V; Tedeschi C; Cristiano C; De Fortuna EM; Messina V; Aliperta A
    Minerva Cardioangiol; 1989 Dec; 37(12):517-9. PubMed ID: 2622539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
    Commeau P; Barragan P; Roquebert PO
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of nitrendipine in treating patients with obliterative atherosclerosis of arteries in the lower extremities].
    Grodzińska L; Kostka-Trabka E; Basista M; Bieroń K; Sławiński M; Telesz E
    Pol Tyg Lek; 1991 Aug 5-19; 46(32-34):598-600. PubMed ID: 1669121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM; Lepore R
    Clin Ter; 1990 Nov; 135(4):273-81. PubMed ID: 2150026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombosis and antithrombotic agents in peripheral artery disease].
    Emmerich J
    Arch Mal Coeur Vaiss; 2002 Nov; 95 Spec No 7():59-62. PubMed ID: 12500607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
    Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    ; Leizorovicz A; Becker F
    Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases].
    Bucci M; Iacobitti P; Laurora G; Cesarone MR
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):9-15. PubMed ID: 10658439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The future prospects of antithrombotic therapy in peripheral vasculopathy].
    Violi F; Loffredo L; Annessi M
    Ann Ital Med Int; 1999; 14(3):185-91. PubMed ID: 10566184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C; Antignani PL; Schachter I; Koverech A; Messano M; Virmani A
    Ann Vasc Surg; 2008; 22(4):552-8. PubMed ID: 18502605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
    Violi F; Balsano F
    Clin Trials Metaanal; 1994 Apr; 29(1):81-7. PubMed ID: 10150187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.